Drug Information Update- February 28, 2010 Deadline to Submit Comments on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools"

"U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Fri, 19 Feb 2010 12:24:00 -0600

Title: Drug Information Update- February 28, 2010 Deadline to Submit Comments on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools" 

The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA. 

	Please note that the deadline to submit comments to docket FDA-2009-N-0441 "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools" is 11:59PM ET on Sunday, February 28, 2010.  Below are instructions for submitting written or electronic comments (you may also refer to the attached Federal Register notice): 

Submit written comments to: 

Division of Dockets Management (HFA-305) 

Food and Drug Administration 

5630 Fishers Lane, rm. 1061 

Rockville, MD 20852. 

Submit electronic comments to http://www.regulations.gov as follows: 

·          Type "FDA-2009-N-0441-0001" into the "Enter Keyword or ID" search field. 

·          In the "Title" column to the left, the first result should be "Public Hearing:  Promotion of Food and Drug Administration-Regulated Medical Products     Using the
 Internet
 and Social Media Tools." 

·          In the "Actions" column to the right of this result, click on "Submit a Comment." 

·          Fill out the required information (you may either type your comments directly into the field or attach a separate file such as Word, PPT, or PDF). 

·          You may preview your comment but please make sure to click the "Submit" button when you are finished. 

If you plan to submit comments but are unable to do so by this deadline, please contact Jean-Ah Kang as soon as possible at InternetPublicMeeting@xxxxxxxxxxx. 

This is an automated message delivery system.  Replying to this message will not reach DDI staff.  If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday.  You can also email us at druginfo@xxxxxxxxxxx. 

  For additional drug information, please visit the DDI Web page. 

  For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info 

  This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA). 

Manage your FDA Subscriptions: 

  Update your preferences or unsubscribe 

  Questions about this service? support@xxxxxxxxxxxxxxx 

  Other inquiries? webmail@xxxxxxxxxx 

			GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA)
			· 5600 Fishers Lane

			· Rockville MD 20857
			· 800-439-1420